Different Doses of Dalpicicl Combined With Letrozole in the First-line Treatment of HR-positive, HER2-negative Advanced Breast Cancer

NCT07285382 · clinicaltrials.gov ↗

PHASE2

Phase

RECRUITING

Status

120

Enrollment

OTHER

Sponsor class

Conditions

HR Positive HER2 Negative Advanced Breast Cancer

Interventions

DRUG: Dalpiciclib 125mg
DRUG: Dalpiciclib 150mg
DRUG: Letrozole 2.5mg

Sponsor

wanghaibo